Inovio Pharmaceuticals, Inc.
CLINICAL AND IMMUNOLOGIC BIOMARKERS FOR REGRESSION OF HIGH GRADE CERVICAL DYSPLASIA AND CLEARANCE OF HPV16 AND HPV18 INFECTION AFTER IMMUNOTHERAPY

Abstract:

Methods for treating a subject infected with human papillomavirus and accompanying symptoms comprise assessing a sample obtained from the patient after the treatment is administered to detect the presence or absence of biomarkers associated with lesion regression and/or clearance of the virus from the subject.